Montash 10 10 mg Tablet
PDF Leaflet Revision Date: 17 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma.
Dosage (summary)
Adults: 1 tablet (10 mg) daily; Children 6-14 years: 1 chewable tablet (5 mg) daily; Children 2-5 years: 1 chewable tablet (4 mg) daily.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; use with caution.
Key Drug Interactions
- Phenobarbital
- CYP inducers
- Warfarin
Contraindications
- Hypersensitivity to montelukast
- Children under 2 years
- Children under 6 years for certain formulations
Common side effects
- Abdominal pain
- Headache
- Dizziness
- Fatigue
Counselling Points
- Take in the evening
- Not a substitute for rescue inhalers
- Report any mood changes
Serious warnings
- Not for acute asthma attacks
- Risk of neuropsychiatric events
- Monitor for eosinophilia
Important Disclaimer
The Montash 10 10 mg Tablet professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
